1–2 tablets given for 4–5 consecutive days at these times:		Total cumulative dose
Treatment year 1	Beginning of 1st month
	Beginning of 2nd month	1.75 mg/kg
Treatment year 2	Beginning of 1st month
	Beginning of 2nd month	3.5 mg/kg

Cladribine tablets is administered orally as 10 mg tablets over 4–5 days for each of the four treatment periods. The number of tablets per day and the number of days of treatment (4 or 5) are determined by the patient’s body weight (see the label for a guide). Treatment is administered orally, with water, in a single tablet intake. Source: European Summary of Product Characteristics for Mavenclad®